Tejnaksh Healthcare shines on launching Andro Sim
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Tejnaksh Healthcare is currently trading at Rs. 114.70, up by 3.35 points or 3.01% from its previous closing of Rs. 111.35 on the BSE.
The scrip opened at Rs. 114.35 and has touched a high and low of Rs. 117.35 and Rs. 109.70 respectively. So far 4549 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 194.00 on 16-Mar-2022 and a 52 week low of Rs. 106.50 on 30-Nov-2021.
Last one week high and low of the scrip stood at Rs. 119.95 and Rs. 109.70 respectively. The current market cap of the company is Rs. 116.50 crore.
The promoters holding in the company stood at 73.83%, while Non-Institutions held 26.17% stake in the company.
Tejnaksh Healthcare has launched Andro Sim. Andro Sim is a silicon model used by doctors to educate patients and doctors as to examine a patient, treat patients with intracavernosal injections, Intraurethral instillations , Practice penile implant surgeries, Urethral dilatation etc. It is the first of its kind simulator ever made globally.
This Product is part of the simulator series launched and promoted by Tejnaksh Healthcare. This simulator will help the Urologist and patient to understand treatment of infertility and andrology more efficiently.
Tejnaksh Healthcare is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities.
